Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000410992 | SCV000486036 | likely pathogenic | Cohen syndrome | 2016-03-18 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000410992 | SCV000822247 | pathogenic | Cohen syndrome | 2024-01-02 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr1016Ilefs*6) in the VPS13B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111). This variant is present in population databases (no rsID available, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with clinical features of Cohen syndrome (Invitae). ClinVar contains an entry for this variant (Variation ID: 370665). For these reasons, this variant has been classified as Pathogenic. |